Cardiac Marker(心臓マーカー)

High-Quality Cardiac Marker Biospecimens for Cardiovascular Research and Diagnostic Development

Explore a broad selection of human biospecimens associated with cardiac biomarkers and cardiovascular disease. Centrallink provides ethically sourced, clinically annotated serum, plasma, whole blood, and tissues ideal for cardiac marker validation, diagnostic assay development, biomarker discovery, and translational cardiology research.

Easily filter samples by cardiac marker levels, disease indication, clinical history, donor demographics, and laboratory parameters. Centrallink ensures high sample integrity and reliable access for heart disease and cardiovascular biomarker studies.

Samples Count:

Export Data
Show rows
|< < of > >|

Centrallink: Your Global Source for Cardiac Marker Biospecimens and Cardiovascular Research Materials

Cardiovascular disease remains a leading global health challenge, increasing the demand for reliable cardiac biomarker data to support diagnostic development, therapeutic innovation, and translational research. Centrallink offers an extensive selection of cardiac marker–associated biospecimens that empower researchers studying heart disease, cardiac injury, and circulatory system disorders. Each sample is ethically sourced, clinically annotated, and preserved under strict quality standards to ensure suitability for advanced cardiac research workflows.

Our biospecimens include serum, plasma, whole blood, PBMCs, tissues, DNA, RNA, and other materials relevant to cardiovascular studies. These samples are accompanied by detailed clinical information such as cardiac enzyme levels, troponin values, BNP/NT-proBNP levels, lipid profiles, ECG findings, comorbidities, medication history, and diagnostic documentation. Such metadata enriches research accuracy and improves biomarker discovery and validation.

Comprehensive Cardiac Marker Annotation for Precision Research

Centrallink provides biospecimens linked to well-established cardiac biomarkers, including cardiac troponins (cTnI, cTnT), CK-MB, myoglobin, BNP, NT-proBNP, D-dimer, CRP, LDH, AST, and other cardiology-related indicators. These biomarkers support studies in myocardial injury, heart failure, acute coronary syndromes, arrhythmias, inflammation-driven cardiac conditions, and cardiovascular risk assessment.

Researchers can filter samples based on cardiac marker values, disease status, risk profiles, sample type, and demographic details. This ensures quick and precise identification of biospecimens that match specific cardiovascular research requirements.

Streamlined Procurement for Cardiology and Diagnostic Development

With Centrallink, researchers can source cardiac marker–associated biospecimens in minutes instead of weeks. Our digital platform offers real-time inventory visibility and a smooth ordering process. Each sample listing provides clinically meaningful details and transparent catalog information, supporting efficient decision-making.

For specialized cardiology research needs — such as specific troponin ranges, matched cohorts, longitudinal samples, or rare clinical profiles — Centrallink offers custom biospecimen sourcing. Our scientific support team collaborates with global partners to fulfill requests tailored to advanced cardiovascular studies.

Advancing Cardiovascular Diagnostics, Biomarker Innovation, and Precision Medicine

High-quality cardiac marker biospecimens are essential for advancing precision cardiology, diagnostic innovation, and biomarker-driven research. Centrallink provides support for studies involving myocardial injury detection, heart failure assessment, thrombosis, vascular inflammation, and multi-omics cardiac research. Our biospecimens enable researchers to perform proteomics, molecular analysis, cytokine evaluation, and advanced cardiovascular modeling.

By offering ethically sourced samples, robust clinical data, and a modern procurement platform, Centrallink empowers researchers to accelerate breakthroughs in cardiovascular science. Whether your focus is diagnostic development, risk evaluation, or translational cardiology, our platform ensures timely access to reliable cardiac marker biospecimens.

Cardiac marker biospecimens are human samples such as serum, plasma, whole blood, and tissues containing clinically measured cardiac biomarkers used to study heart disease, cardiac injury, and cardiovascular disorders.
Markers may include cTnI, cTnT, CK-MB, myoglobin, BNP, NT-proBNP, D-dimer, CRP, LDH, AST, and other cardiology-related biomarkers depending on availability.
Clinical annotations may include cardiac enzyme levels, lipid profiles, ECG findings, blood pressure, diagnosis, disease severity, medication history, and comorbidities.
These biospecimens support cardiovascular diagnostics development, biomarker validation, myocardial injury studies, heart failure research, inflammatory cardiac research, and translational cardiology.
Yes. Researchers can request specific marker ranges, rare disease samples, matched cohorts, longitudinal samples, and other specialized cardiac biospecimens.